Literature DB >> 182574

Apparent multiple forms of cyclic AMP phosphodiesterase from rat erythrocytes.

W D Patterson, J G Hardman, E W Sutherland.   

Abstract

Bio-Gel A-5m chromatography has been used to separate apparent multiple forms of cyclic nucleotide phosphodiesterase from rat erythrocytes. Cyclic AMP phosphodiesterase was resolved by gel filtration into three peaks of activity with apparent molecular weights of about 300,000, 225,000 and 100,000, while cyclic GMP phosphodiesterase activity in gel column fractions was too low to permit meaningful estimates of its molecular weight. All three of the separated peaks of cyclic AMP phosphodiesterase activity displayed anomalous kinetic behaviour suggestive of negative cooperativity. The possibility that multiple phosphodiesterase activities could arise from in vitro alterations of a single enzyme was investigated. Similar changes in gel filtration profiles resulted when erythrocyte extracts were treated with trypsin or ammonium sulfate or were incubated at 37 degrees C. After these treatments, a large proportion of the enzyme activity occurred in low (ca. 100,000) molecular weight regions. The low molecular weight phosphodiesterase activities from untreated, incubated, and trypsin-treated extracts possessed similar properties. All were inhibited by methylxanthines, had pH optima of approximately 8.0, and similar kinetic properties and requirements for divalent cations. These observations raise the possibility that preparative procedures or limited proteolysis occurring during preparation and handling of extracts can contribute to the apparent multiplicity of enzyme forms seen after gel filtration of phosphodiesterase from rat erythrocytes and perhaps other cell types.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182574     DOI: 10.1016/0303-7207(76)90070-8

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  Cyclic nucleotide phosphodiesterase activities in rat erythrocytes.

Authors:  M T Téllez-Iñón; H N Torres
Journal:  Mol Cell Biochem       Date:  1982-04-02       Impact factor: 3.396

2.  Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Randy S Sprague
Journal:  Exp Biol Med (Maywood)       Date:  2010-02

Review 3.  Regulation of cAMP by phosphodiesterases in erythrocytes.

Authors:  Shaquria P Adderley; Randy S Sprague; Alan H Stephenson; Madelyn S Hanson
Journal:  Pharmacol Rep       Date:  2010 May-Jun       Impact factor: 3.024

4.  Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.

Authors:  Madelyn S Hanson; Alan H Stephenson; Elizabeth A Bowles; Meera Sridharan; Shaquria Adderley; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

5.  Regulation of cyclic AMP metabolism in the rat erythrocyte during chronic beta-adrenergic stimulation. Evidence for calmodulin-mediated alteration of membrane-bound phosphodiesterase activity.

Authors:  C A Clayberger; D B Goodman; H Rasmussen
Journal:  J Membr Biol       Date:  1981-02-28       Impact factor: 1.843

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.